Navidea Completes Sale Of North American Rights Of Lymphoseek To Cardinal Health Post author:Sam Post published:March 5, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like How Immigration Ban is Already Hurting Science January 29, 2017 IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017 Agenus Appoints Chief Medical Officer January 29, 2017
IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017